Medicinal and Pharmaceutical Chemistry Commons^™

Discovery Of Pyrazolopyridine Derivatives Dually Targeting Inflammation And Proliferation In Colorectal Cancer Cell Lines: In-Silico Drug Design Approach, Zahra Kassem, Raghida Bou Merhi, Doaa Issa

BAU Journal - Health and Wellbeing

Elimination of inflammation represents a promising strategy for cancer prevention and treatment since cancer and inflammation are related. The combined use of anti-inflammatory agents and cancer therapy is a focal point. In this frame, pyrazolopyridine derivatives DZ-BAU2021-6 and DZ-BAU2021-14, developed in BAU Labs, having promising anti-proliferative activity on colon cancer cells HCT-116 and HT-29 with notable IC50 values and remarkable CDK2 inhibitory effect, were in-silico tested. As an approach to dual anti-inflammatory anticancer potential, their binding modes and energies on the active site of crystalline structure of CDK2 and COX2, (1HCK and 3LN1), respectively were explored. Their physicochemical and pharmacokinetic …